- Home
- LGL vs VRCA Comparison
LGL vs VRCA Comparison
Compare LGL & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- VRCA
- Stock Information
- Founded
- LGL 1917
- VRCA 2013
- Country
- LGL United States
- VRCA United States
- Employees
- LGL N/A
- VRCA N/A
- Industry
- LGL Industrial Machinery/Components
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- VRCA Health Care
- Exchange
- LGL Nasdaq
- VRCA Nasdaq
- Market Cap
- LGL 37.5M
- VRCA 43.0M
- IPO Year
- LGL N/A
- VRCA 2018
- Fundamental
- Price
- LGL $6.40
- VRCA $0.54
- Analyst Decision
- LGL
- VRCA Hold
- Analyst Count
- LGL 0
- VRCA 5
- Target Price
- LGL N/A
- VRCA $6.00
- AVG Volume (30 Days)
- LGL 5.8K
- VRCA 246.4K
- Earning Date
- LGL 05-23-2025
- VRCA 05-13-2025
- Dividend Yield
- LGL N/A
- VRCA N/A
- EPS Growth
- LGL 59.20
- VRCA N/A
- EPS
- LGL 0.08
- VRCA N/A
- Revenue
- LGL $4,292,000.00
- VRCA $7,179,000.00
- Revenue This Year
- LGL N/A
- VRCA $127.58
- Revenue Next Year
- LGL N/A
- VRCA $88.06
- P/E Ratio
- LGL $85.81
- VRCA N/A
- Revenue Growth
- LGL 16.69
- VRCA N/A
- 52 Week Low
- LGL $4.86
- VRCA $0.38
- 52 Week High
- LGL $7.28
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- LGL 45.18
- VRCA 57.01
- Support Level
- LGL $6.12
- VRCA $0.39
- Resistance Level
- LGL $6.87
- VRCA $0.48
- Average True Range (ATR)
- LGL 0.19
- VRCA 0.05
- MACD
- LGL -0.05
- VRCA 0.01
- Stochastic Oscillator
- LGL 29.17
- VRCA 90.75
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.